448 related articles for article (PubMed ID: 30615886)
1. Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI.
Chen Y; Meng J; Xu Q; Long T; Bi F; Chang C; Liu W
Brain Res; 2019 May; 1710():163-172. PubMed ID: 30615886
[TBL] [Abstract][Full Text] [Related]
2. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
[TBL] [Abstract][Full Text] [Related]
3. MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury.
Ismael S; Nasoohi S; Ishrat T
J Neurotrauma; 2018 Jun; 35(11):1294-1303. PubMed ID: 29295651
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke.
Ismael S; Zhao L; Nasoohi S; Ishrat T
Sci Rep; 2018 Apr; 8(1):5971. PubMed ID: 29654318
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
6. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease.
Huang S; Chen Z; Fan B; Chen Y; Zhou L; Jiang B; Long H; Zhong W; Li X; Li Y
J Neuroimmunol; 2021 May; 354():577543. PubMed ID: 33714750
[TBL] [Abstract][Full Text] [Related]
7. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats.
Zhao J; Guo X; Wang B; Yang Z; Huang T; Guo D; Zhang M; Song J
Neurochem Res; 2020 Sep; 45(9):2020-2031. PubMed ID: 32474832
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin reduces brain injury after intracerebral hemorrhage by reducing NLRP3 inflammasome expression.
Wang S; Yao Q; Wan Y; Wang J; Huang C; Li D; Yang B
Int J Neurosci; 2020 Mar; 130(3):301-308. PubMed ID: 31607194
[No Abstract] [Full Text] [Related]
9. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion.
Wang H; Chen H; Jin J; Liu Q; Zhong D; Li G
Life Sci; 2020 Jun; 251():117638. PubMed ID: 32251636
[TBL] [Abstract][Full Text] [Related]
10. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation.
Li S; Lin Q; Shao X; Mou S; Gu L; Wang L; Zhang Z; Shen J; Zhou Y; Qi C; Jin H; Pang H; Ni Z
Exp Cell Res; 2019 Oct; 383(1):111488. PubMed ID: 31276670
[TBL] [Abstract][Full Text] [Related]
12. MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats.
Luo Y; Lu J; Ruan W; Guo X; Chen S
Brain Res Bull; 2019 Mar; 146():320-326. PubMed ID: 30716395
[TBL] [Abstract][Full Text] [Related]
13. Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice.
Ren P; Wu D; Appel R; Zhang L; Zhang C; Luo W; Robertson AAB; Cooper MA; Coselli JS; Milewicz DM; Shen YH; LeMaire SA
J Am Heart Assoc; 2020 Apr; 9(7):e014044. PubMed ID: 32223388
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S
Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow a confers neuroprotection against acute traumatic brain injury by modulating neuronal autophagy to inhibit NLRP3 inflammasomes.
Lai Z; Li C; Ma H; Hua S; Liu Z; Huang S; Liu K; Li J; Feng Z; Cai Y; Zou Y; Tang Y; Jiang X
J Ethnopharmacol; 2023 May; 308():116268. PubMed ID: 36842723
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.
Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425
[TBL] [Abstract][Full Text] [Related]
17. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.
Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L
Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320
[TBL] [Abstract][Full Text] [Related]
18. Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS.
Liu H; You L; Wu J; Zhao M; Guo R; Zhang H; Su R; Mao Q; Deng D; Hao Y
J Leukoc Biol; 2020 Jul; 108(1):253-266. PubMed ID: 32272506
[TBL] [Abstract][Full Text] [Related]
19. Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model.
Zhang W; Ba G; Tang R; Li M; Lin H
Int Immunopharmacol; 2020 Jun; 83():106394. PubMed ID: 32193102
[TBL] [Abstract][Full Text] [Related]
20. Honokiol-Mediated Mitophagy Ameliorates Postoperative Cognitive Impairment Induced by Surgery/Sevoflurane via Inhibiting the Activation of NLRP3 Inflammasome in the Hippocampus.
Ye JS; Chen L; Lu YY; Lei SQ; Peng M; Xia ZY
Oxid Med Cell Longev; 2019; 2019():8639618. PubMed ID: 30918581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
